INTRODUCTION
Visceral obesity is strongly associated with metabolic risk factors, such as hyperglycemia, hypertension, and hyperlipidemia 1 3 . The development of obesity is related to genetic background, physical activity, and diet composition. In particular, a chronic imbalance between fat intake and fat expenditure is an important regulator of body fat 4 .
Moreover, dietary fat ingestion may be related to fat oxidation 5 7 .
Alpha linolenic acid-enriched diacylglycerol ALA-DAG is a minor natural component of many edible oils and has long been consumed by humans. ALA-DAG mainly occurs with the chemical structure 1,3-diacyl-sn-glycerol 1,3-DAG and alpha-linolenic acid as the fatty acid. Previous human studies demonstrated that the long-term consumption of ALA-DAG significantly decreases body weight and visceral fat area compared to consuming the control triacylglycerol TAG 8 10 . ALA-DAG consumption enhances both fat oxidation and energy expenditure in healthy humans 11 . Thus, ALA-DAG consumption could be useful for controlling body weight by maintaining or improving fat and energy metabolism. This underlying mechanism is supported by reports showing enhanced expression of β-oxidation related enzymes and genes in the small intestine 12 and in the liver 13 in rodents. Based on these reports, ALA-DAG is expected to enhance oxidation of diet-derived fat as well as body fat. Indeed, in rodents, dietary fat oxidation is enhanced after repeated ingestion of ALA-DAG compared to TAG 14 . Its effect in humans, however, remains unclear. Therefore, this study evaluated whether repeated ALA-DAG consumption affects oxidation of diet-derived fat in healthy human subjects.
Network Clinical Trials Registry registration no. UMIN000021181 , and the execution of this study was outsourced to TES Holdings Co., Ltd Tokyo, Japan . After receiving an explanation of the study, all subjects provided written informed consent to participate in the study.
Subjects
Twenty subjects were enrolled in the study according to the inclusion and exclusion criteria. Inclusion criteria were 1 age 35 to 64 years and 2 body mass index 23.0 to 29.9 kg/m 2 . Exclusion criteria included the presence of severe disease, surgery within 2 months, taking medication, taking supplements or foods with health claims, premenopausal woman, and food allergy. The sample size was estimated based on our previous study showing that ALA-DAG significantly enhanced postprandial total fat oxidation in 19 subjects 11 . Because the dose and the consumption duration of ALA-DAG in this present study were the same as the previous study, we estimated that a similar sample size was appropriate.
Design and protocol
The study had a randomized, double-blind, placebo-controlled crossover design with two 14-d consumption periods of ALA-DAG or control TAG, separated by a 21-d washout period. The subjects were assigned to each order of the consumption period by stratified block randomization using computer-generated random numbers under blinded condition. During each consumption period, the subjects consumed shortbreads containing 2.5 g/d of ALA-DAG or TAG each day. During the consumption period, the subjects were instructed to maintain their habitual lifestyle, including their usual physical activity and dietary intake. The subjects recorded their meals for 3-d before the measurements, and nationally registered dietitians analyzed the dietary records. Alcohol intake and strenuous exercise were not allowed for the 3-d before each measurement. One day before the measurements, the subjects ingested specified meals for breakfast, lunch, and dinner total calories: 2173 kcal/day for men, 1818 kcal/day for women . At the end of the consumption period, we measured the subjects body composition and dietary fat oxidation, and collected serum samples after they had fasted for at least 12 h.
Test diet
We used a previously reported method 15 to prepare the ALA-DAG from flaxseed oil Summit Oil Corporation, Chiba, Japan and rapeseed oil The Nisshin OilliO Group, Ltd, Tokyo, Japan using equipment owned by Kao Corporation Tokyo, Japan . Each 2.5 g of ALA-DAG contained 0.9 g DAG-bound ALA. Rapeseed oil was used as the source of the TAG The Nisshin OilliO Group, Ltd, Tokyo, Japan . Table 1 shows the components of the TAG and ALA-DAG. We produced a cooking oil by mixing the ALA-DAG with rapeseed oil, anti-oxidants, and emulsifying agents. We made a test shortbread hard flour, soft flour, superfine sugar, salt, egg, pullulan, water, and the prepared cooking oil to ensure accurate ingestion of the ALA-DAG or TAG. Each shortbread 60 g contained 291 kcal protein:fat:carbohydrate 8:39:53 per serving 2.5 g ALA-DAG or TAG and were individually packaged. The shortbreads containing TAG and ALA-DAG could not be distinguished from each other by appearance, taste, or odor.
Dietary fat oxidation assessment
We synthesized the 13 C-labelled triolein probes from 1-13 C oleic acid purity 99 , 13 C 99 ; Isotec, Miamisburg, OH, US and free glycerol using an enzymatic method and purified the probes using silica gel liquid chromatography. The assessment of dietary fat oxidation was performed as reported previously 16 18 . Briefly, before and after ingestion of the test meal 555 kcal, protein: fat: carbohydrate 17:30:52 as energy value containing 13 C-labelled triolein 400 mg , we collected breath samples in aluminum bags GL Science Inc., Tokyo, Japan every hour for 6 h. As the primary outcome, oxidation of dietary fat was assessed by measuring recovery rate of ingested 13 C-labelled triolein to 13 CO 2 in the breath. Recovery rate of 13 C was assessed by the combined use of an indirect calorimeter Arco Systems Inc., Chiba, Japan and an stable isotope ratio mass spectrometer ANCA-GSL; Sercon, Crewe, UK . 
Statistical analysis
Data are expressed as mean SD. Comparisons of the difference in two periods between the ALA-DAG treatment followed by the TAG treatment and the TAG treatment followed by the ALA-DAG treatment were performed using a two-sample t-test. A p-value of less than 0.05 was considered statistically significant.
RESULTS

Subjects and characteristics
Sixteen subjects 11 men and 5 women completed the measurements and were included in the analyses, and 4 subjects did not complete the measurements. The baseline physical characteristics, including body composition, serum triglyceride, glucose, insulin, non-esterified fatty acid, total-, low-density-, and high-density-cholesterol did not significantly differ between the treatment orders. Table  2 shows the physical characteristics of the subjects after the treatments. Body fat ratio and fat mass were significantly lower after the ALA-DAG treatment compared with the TAG treatment. The serum parameters did not significantly differ after the treatments between ALA-DAG and TAG data not shown .
Outcomes
The 13 C recovery at the 1 h time-point 
DISCUSSION
In the present study, to gain further insight into the mechanism underlying the anti-visceral obesity effect of ALA-DAG, the recovery rate of 13 C-labelled dietary fat to 13 CO 2 in the breath was assessed as an indicator of dietary fat oxidation during either ALA-DAG or TAG treatment. The ALA-DAG treatment enhanced dietary fat utilization as energy compared to the TAG treatment in humans. Taken together with our previous data showing increased postprandial total fat oxidation and energy expenditure after treatment with ALA-DAG 11 , these findings suggest that ALA-DAG treatment induces up-regulation of dietary fat metabolism and contributes to prevent visceral obesity. Indeed, significantly decreased fat mass Table 2 and significantly increased dietary fat oxidation Fig. 1 were both observed in this present study. Repeated consumption of ALA-DAG enhances β-oxidation in the small intestine 12 and liver 13 in rodents. Although the precise mechanism by which ALA-DAG consumption stimulates gene expression is not clear, it may be related to the metabolic pathway of ALA-DAG. In general, the TAG structure is hydrolyzed by lipase to 2-monoacylglycerol MAG and fatty acids and then resynthesized into TAG in the intestinal mucosa cells. In contrast, the DAG structure is hydrolyzed to 1-or 3 MAG and fatty acids. Because 1-MAG is not easily resynthesized to TAG in the small intestine 19, 20 , the 1-MAG and free fatty acids may remain in the intestinal mucosa cells after DAG consumption 21 . Omega 3 fatty acids, such as ALA, eicosapentaenoic acid, and docosahexaenoic acid increase the gene expressions including farnesoid X receptor and peroxisome proliferator-activated receptor compared to other fatty acids, such as saturated and omega 6 fatty acids 22 , suggesting that the free ALA derived from ALA-DAG activates fat oxidation and suppress fat synthesis, particularly in the small intestine and the liver. Thus, DAG and ALA can synergistically affect fat oxidation. Indeed, Murase et al. suggested that β-oxidation is higher in rodents fed ALA-DAG than in those fed ALA-TAG 12 . Additionally, ALA-DAG can enhance fat oxidation at 25 of the dose compared to oleic and linolenic acid-riched DAG 16 .
A limitation of the present study is that the ALA-DAG shortbread contained more ALA than the control TAG shortbread because we did not adjust the fatty acids component. Therefore, we cannot determine whether the DAG structure or the fatty acid composition was the major factor inducing the ALA-DAG effects. Additional studies with a similar fatty acid composition are required.
CONCLUSION
Treatment with ALA-DAG for 14-d enhanced the utilization of dietary fat as energy in healthy humans. This result indicates that ALA-DAG consumption has beneficial effects for preventing visceral obesity by upregulating dietary fat metabolism.
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